Current results and prospective trials of cladribine in chronic lymphocytic leukemia.
Tallman
M S
MS
Robert H. Lurie Cancer Center of Northwestern University, Chicago, IL, USA.
Hakimian
D
D
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D017338:Cladribine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D011446:Prospective Studies; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D002699:Chlorambucil; D017338:Cladribine; D014740:Vidarabine; C024352:fludarabine